Orca Bio is a late-stage biotechnology company developing high-precision allogeneic cell therapies for the treatment of cancer and autoimmune diseases. Its approach engineers purified cell populations, including regulatory T cells, to improve patient outcomes while reducing the risks associated with traditional allogeneic transplant. - View it on GitHub